Single Centre Study to Determine the Antibody Response to G17DT in Patients With Advanced Pancreatic Cancer.
Clinical trial NCT02098239 · COMPLETED
Trial details
- NCT number
- NCT02098239
- Sponsor
- Cancer Advances Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1999-08-01
- Primary completion
- 2002-04-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.